Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Healthcare ETF Vanguard (VHT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Fund Family Vanguard Group
  • Assets Under Management 6,729,129,600
  • Shares Outstanding, K 44,774

Price Performance

See More
Period Period Low Period High Performance
1-Month
139.62 +7.73%
on 05/24/17
151.23 -0.54%
on 06/22/17
+10.45 (+7.47%)
since 05/23/17
3-Month
135.40 +11.09%
on 04/18/17
151.23 -0.54%
on 06/22/17
+12.91 (+9.39%)
since 03/23/17
52-Week
120.38 +24.95%
on 11/03/16
151.23 -0.54%
on 06/22/17
+20.45 (+15.74%)
since 06/23/16

Most Recent Stories

More News
Top-Ranked Health Care ETFs to Buy Now

After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.

RYH : 176.32 (+0.11%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
IHF : 149.10 (+0.03%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
Top-Ranked Health Care ETFs to Buy Now

After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.

RYH : 176.32 (+0.11%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
IHF : 149.10 (+0.03%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
How to Trade "Sell in May and Go Away" With ETFs

The stock market has a long history of weak performance during the summer months (May to October).

USMV : 49.68 (+0.02%)
SPLV : 45.12 (+0.07%)
FDLO : 27.89 (-0.14%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
DEF : 42.86 (-0.12%)
ACWI : 65.54 (+0.17%)
PSQ : 39.42 (-0.35%)
VDC : 143.36 (+0.02%)
SH : 33.32 (-0.12%)
IYH : 169.33 (-0.12%)
IYK : 123.20 (+0.29%)
XLP : 55.49 (+0.04%)
SPY : 243.13 (+0.12%)
DOG : 17.40 (unch)
How to Trade "Sell in May and Go Away" With ETFs

The stock market has a long history of weak performance during the summer months (May to October).

USMV : 49.68 (+0.02%)
SPLV : 45.12 (+0.07%)
FDLO : 27.89 (-0.14%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
DEF : 42.86 (-0.12%)
ACWI : 65.54 (+0.17%)
PSQ : 39.42 (-0.35%)
VDC : 143.36 (+0.02%)
SH : 33.32 (-0.12%)
IYH : 169.33 (-0.12%)
IYK : 123.20 (+0.29%)
XLP : 55.49 (+0.04%)
SPY : 243.13 (+0.12%)
DOG : 17.40 (unch)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 150.41 (+0.04%)
JNJ : 136.43 (+0.28%)
MRK : 66.16 (+0.21%)
IYH : 169.33 (-0.12%)
FHLC : 38.92 (+0.03%)
ABBV : 72.64 (-0.74%)
AMG : 161.27 (-0.48%)
GILD : 70.52 (+0.06%)
SPY : 243.13 (+0.12%)
AMGN : 172.50 (-0.76%)
PFE : 34.17 (+0.32%)
BMY : 56.64 (-1.20%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 150.41 (+0.04%)
JNJ : 136.43 (+0.28%)
MRK : 66.16 (+0.21%)
IYH : 169.33 (-0.12%)
FHLC : 38.92 (+0.03%)
ABBV : 72.64 (-0.74%)
AMG : 161.27 (-0.48%)
GILD : 70.52 (+0.06%)
SPY : 243.13 (+0.12%)
AMGN : 172.50 (-0.76%)
PFE : 34.17 (+0.32%)
BMY : 56.64 (-1.20%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
JNJ : 136.43 (+0.28%)
IHE : 159.71 (-0.03%)
IYH : 169.33 (-0.12%)
FHLC : 38.92 (+0.03%)
PFE : 34.17 (+0.32%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
JNJ : 136.43 (+0.28%)
IHE : 159.71 (-0.03%)
IYH : 169.33 (-0.12%)
FHLC : 38.92 (+0.03%)
PFE : 34.17 (+0.32%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 134.31 (+0.47%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
MDCO : 38.60 (+1.18%)
IBB : 320.74 (+0.20%)
PFE : 34.17 (+0.32%)
ESPR : 44.34 (+4.80%)
BBP : 41.35 (+0.39%)
XPH : 43.92 (+0.27%)
ABT : 49.08 (-0.39%)
TMO : 174.44 (-0.59%)
PJP : 63.72 (+0.31%)
IYH : 169.33 (-0.12%)
AMG : 161.27 (-0.48%)
BIIB : 280.32 (-0.09%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 134.31 (+0.47%)
XLV : 80.47 (-0.15%)
VHT : 150.41 (+0.04%)
MDCO : 38.60 (+1.18%)
IBB : 320.74 (+0.20%)
PFE : 34.17 (+0.32%)
ESPR : 44.34 (+4.80%)
BBP : 41.35 (+0.39%)
XPH : 43.92 (+0.27%)
ABT : 49.08 (-0.39%)
TMO : 174.44 (-0.59%)
PJP : 63.72 (+0.31%)
IYH : 169.33 (-0.12%)
AMG : 161.27 (-0.48%)
BIIB : 280.32 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Fund Summary

The Vanguard Health Care ETF seeks to track the performance of the MSCI US Investable Market Health Care 25/50 Index.

See More

Top 10 Holdings

Support & Resistance

2nd Resistance Point 151.19
1st Resistance Point 150.80
Last Price 150.41
1st Support Level 149.78
2nd Support Level 149.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.